“From advanced skin boosters, polynucleotides, dermal fillers, fat dissolvers, and chemical peels, to essential clinic supplies, our portfolio is designed to enhance the outcomes of your treatments while safeguarding patient trust.”
Not loaded yet. See them on Companies House
People and entities with significant control, from the Companies House PSC register
Balance sheet as at 31 May 2025 · total exemption full accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Fixed Assets | £33,755 | £36,038 | £58,596 | £12,362 | |
| Current Assets | £140,937 | £273,667 | £1,193,485 | £398,048 | |
| Debtors | £65,516 | £67,450 | £327,100 | £125,508 | |
| Cash | £24,788 | £149,780 | £829,231 | £129,505 | |
| Creditors (< 1 year) | £72,200 | £138,355 | £369,183 | £753,811 | £281,672 |
| Creditors (> 1 year) | £0 | £100,000 | |||
| Net Current Assets | £68,737 | £135,312 | £439,674 | £116,376 | |
| Net Assets | £498,270 | £28,738 | |||
| Shareholder Funds | £102,492 | £171,350 | £498,270 | £28,738 |
Filing history not loaded yet. See it on Companies House
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →